Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-26 @ 2:24 AM
Study NCT ID:
NCT04997902
Status:
COMPLETED
Last Update Posted:
2025-12-23
First Post:
2021-07-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Sponsor:
Kura Oncology, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-27
First Submit QC Date:
None
Study First Post Date:
2021-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-19
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED